Sequoia Vaccines, Inc. (SQVI)

Sequoia Vaccines Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2022	Dec 31, 2021
Net Income	-3.21	-5.33	-7.08
Depreciation & Amortization	0.01	0.01	0.01
Share-Based Compensation	-	0.05	0.04
Other Operating Activities	0.28	0.14	4.69
Operating Cash Flow	-2.92	-3.99	-1.71
Capital Expenditures	-0.01	-0.01	-0.01
Acquisitions	-	-	0.03
Investing Cash Flow	-0.01	-0.01	0.02
Share Issuance / Repurchase	-	2.1	1.64
Debt Issued / Paid	-	-0.02	-0.01
Financing Cash Flow	2.64	2.08	1.63
Net Cash Flow	-0.29	-1.92	-0.06
Free Cash Flow	-2.93	-3.99	-1.71

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).